Cargando…
免疫检查点抑制剂在小细胞肺癌中的临床研究进展
Small cell lung cancer (SCLC) is a poorly differentiated high-grade neuroendocrine tumor, accounts for approximately 14% of all lung cancers. SCLC is characterized by rapid growth, early metastasis without effective treatments after recurrence. It is urgently need to improve the therapy of patients...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973375/ https://www.ncbi.nlm.nih.gov/pubmed/28935016 http://dx.doi.org/10.3779/j.issn.1009-3419.2017.09.06 |